NxStage Medical Reports Third Quarter 20...(610 649 Deferred revenu...),Health
610 649
Deferred revenue 15,944 229
Long-term debt 2,517 4,617
Total liabilities 37,523 18,316
Commitments and contingencies
Stockholders' equity:
Undesignated preferred stock: par
value $0.001, 5,000,000 shares authorized;
zero shares issued and outstanding as
of September 30, 2007 and December 31, 2006 - -
Common stock: par value $0.001,
100,000,000 shares authorized:
30,078,238 and 27,806,543 shares
issued and outstanding as of
September 30, 2007 and December 31,
2006, respectively 30 28
Additional paid-in capital 227,668 206,848
Accumulated deficit (164,639) (123,640)
Accumulated other comprehensive income 401 173
Total stockholders' equity 63,460 83,409
Total liabilities and stockholders'
equity $100,983 $101,725
Revenue by Market
Three Months Ended Nine Months Ended
September 30, September 30,
2007 2006 2007 2006
Chronic care market $8,318 $3,646 $20,498 $8,125
Critical care market 3,307 1,866 9,532 5,334
Total revenues $11,625 $5,512 $30,030 $13,459
Business Metrics
Q3 2007 Q2 2007
September 30, June 30, December 31, September 30,
2007 200
'/>"/>
| SOURCE NxStage Medical, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |